The stromal derived factor-1\CXCR4 axis - A legitimate therapeutic target in multiple myeloma?

Ben Zion Katz*, Sigal Tavor

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1067-1068
Number of pages2
JournalLeukemia and Lymphoma
Volume50
Issue number7
DOIs
StatePublished - 2009

Cite this